Fmoc-R-3-amino-4-(3-trifluoromethylphenyl)-butyric acid, 97%, 1g

1-[1-(2-Chlorophenyl)-2-(trimethylsilyl)ethyl]-1H-1,2,3-benzotriazole, 100mg

beta-Cyclodextrin>98.0%(HPLC)25g

(2E)-1-(2,4-dichlorophenyl)-3-(2,4-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

tert-butyl p-tolylcarbamate, 95.0%, 5g

tert-Butyl 5-bromo-3-iodo-1H-indole-1-carboxylate, 95%, 10g

4-Bromo-2-hydroxypyridine, 95.0%, 10g

(S)-1-Benzyl 3-methyl pyrrolidine-1,3-dicarboxylate, 95.0%, 5g

2-(Oxiran-2-ylmethyl)-1H-isoindole-1,3(2H)-dione, 97.0%, 1g

2-(8-Ethyl-7-fluoro-3-(methoxymethoxy)naphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 10g

1,1-Dimethyl-2,3-dihydrobenzo[d][1,3]azasilin-4(1H)-one, 97%, 250mg

3-AMINO-1-(TRIFLUOROMETHYL)CYCLOBUTAN-1-OL HCL, 95.0%, 10g

2-Phenylcarbamoyl-1,4-naphthoquinone-4-(4-diethylamino-2-methylphenyl)imine>98.0%(T)5g